1. Home
  2. FCEL vs BWAY Comparison

FCEL vs BWAY Comparison

Compare FCEL & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$6.63

Market Cap

370.1M

Sector

Energy

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.71

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCEL
BWAY
Founded
1969
2003
Country
United States
Israel
Employees
629
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
370.1M
450.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FCEL
BWAY
Price
$6.63
$13.71
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$8.31
$13.25
AVG Volume (30 Days)
1.2M
118.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.91
$301.23
Revenue Next Year
$35.84
$24.33
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$3.58
$7.84
52 Week High
$11.99
$26.63

Technical Indicators

Market Signals
Indicator
FCEL
BWAY
Relative Strength Index (RSI) 38.96 29.80
Support Level $6.35 $11.55
Resistance Level $10.69 $17.20
Average True Range (ATR) 0.65 1.07
MACD -0.15 -0.81
Stochastic Oscillator 1.80 15.32

Price Performance

Historical Comparison
FCEL
BWAY

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: